BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 189208)

  • 1. Regulation of cyclic GMP in cerebellum by a striatal dopaminergic mechanism.
    Biggio G; Guidotti A
    Nature; 1977 Jan; 265(5591):240-2. PubMed ID: 189208
    [No Abstract]   [Full Text] [Related]  

  • 2. Kainic acid-induced lesion of dopaminergic target cells in the striatum: consequences on the dynamics of cerebellar cGMP.
    Biggio G; Corda MG; Casu M; Gessa GL
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Aug; 304(1):5-7. PubMed ID: 211448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Striato-cerebellar pathway controlling cyclic GMP content in the cerebellum: role of dopamine, GABA and enkephalins.
    Biggio G; Corda MG; Casu M; Gessa GL
    Adv Biochem Psychopharmacol; 1978; 18():227-44. PubMed ID: 206110
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclic nucleotide levels in the rat striatum and cerebellum--in vivo effects of dopamine and acetylcholine receptor agonists and antagonists.
    Puri SK; Choma P; Volicer L
    Biochem Pharmacol; 1978; 27(19):2333-6. PubMed ID: 215154
    [No Abstract]   [Full Text] [Related]  

  • 5. Participation of an endogenous Ca++-blinding protein activator in the development of drug-induced supersensitivity of striatal dopamine receptors.
    Gnegy M; Uzunov P; Costa E
    J Pharmacol Exp Ther; 1977 Sep; 202(3):558-64. PubMed ID: 19618
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of striatal dopamine receptors in the regulation of cerebellar cyclic GMP.
    Biggio G; Corda MG; Casu M; Gessa GL
    Ann Ist Super Sanita; 1978; 14(1):147-56. PubMed ID: 227304
    [No Abstract]   [Full Text] [Related]  

  • 7. Apomorphine-induced inhibition of striatal dopamine release: role of dopaminergic receptors in substantia nigra.
    Maggi A; Bruno F; Cattabeni F; Groppetti A; Parenti M; Racagni G
    Brain Res; 1978 Apr; 145(1):180-4. PubMed ID: 205324
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacologically induced changes in the 3':5'-cyclic guanosine monophosphate content of rat cerebellar cortex: difference between apomorphine, haloperidol and harmaline.
    Biggio G; Costa E; Guidotti A
    J Pharmacol Exp Ther; 1977 Jan; 200(1):207-15. PubMed ID: 13199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apomorphine increases the activity of rat globus pallidus neurons.
    Bergstrom DA; Bromley SD; Walters JR
    Brain Res; 1982 Apr; 238(1):266-71. PubMed ID: 7083021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic receptor activity in substantia nigra in the mechanisms of autoregulation of striatal dopamine release.
    Groppetti A; Parenti M; Cattabeni F; Maggi A; De Angelis L; Monduzzi M; Racagni G
    Adv Biochem Psychopharmacol; 1978; 19():363-71. PubMed ID: 696464
    [No Abstract]   [Full Text] [Related]  

  • 11. Stratial content of Ca2+-dependent regulator protein and dopaminergic receptor function.
    Lucchelli A; Guidotti A; Costa E
    Brain Res; 1978 Oct; 155(1):130-5. PubMed ID: 28815
    [No Abstract]   [Full Text] [Related]  

  • 12. GABA-receptors in the substantia nigra controlling cyclic-GMP in the cerebellar cortex.
    Biggio G; Corda MG; Casu M; Mulas ML; Gessa GL
    Adv Exp Med Biol; 1979; 123():419-27. PubMed ID: 229716
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of haloperidol and apomorphine treatment on dopamine receptors in pituitary and striatum.
    Friend WC; Brown GM; Jawahir G; Lee T; Seeman P
    Am J Psychiatry; 1978 Jul; 135(7):839-41. PubMed ID: 665797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced striatal acetylcholine release by chlorpromazine and its reversal by apomorphine.
    Stadler H; Lloyd KG; Gadea-Ciria M; Bartholini G
    Brain Res; 1973 Jun; 55(2):476-80. PubMed ID: 4351628
    [No Abstract]   [Full Text] [Related]  

  • 15. On the cyclic nucleotides involvement in rat striatal function.
    Carenzi A; Govoni S; Spano PF; Trabucchi M
    Pharmacol Res Commun; 1976 Oct; 8(5):519-24. PubMed ID: 194261
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of estrogen on changes in the activity of striatal cholinergic neurons induced by DA drugs.
    Euvrard C; Labrie F; Boissier JR
    Brain Res; 1979 Jun; 169(1):215-20. PubMed ID: 455094
    [No Abstract]   [Full Text] [Related]  

  • 17. The pathophysiology of tardive dyskinesia.
    Klawans HL; Carvey P; Tanner CM; Goetz CG
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):38-41. PubMed ID: 2858479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of amantadine HCl on haloperidol-induced striatal dopamine neuron hypersensitivity.
    Allen RM; Flemenbaum A
    Biol Psychiatry; 1979 Jun; 14(3):541-4. PubMed ID: 573144
    [No Abstract]   [Full Text] [Related]  

  • 19. In vivo microdialysis studies of striatal level of neurotransmitters after haloperidol and chlorpromazine administration.
    Kulkarni SK; Bishnoi M; Chopra K
    Indian J Exp Biol; 2009 Feb; 47(2):91-7. PubMed ID: 19374163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The demonstration in vivo of specific binding sites for neuroleptic drugs in mouse brain.
    Höllt V; Czlonkowski A; Herz A
    Brain Res; 1977 Jul; 130(1):176-83. PubMed ID: 560239
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.